myMedidata Wins "Best Patient Portal" Award in 2021 MedTech Breakthrough Awards Program

Annual Awards Program Recognizes Outstanding Health and Medical Technology Products and Companies

NEW YORK – May 6, 2021 – Medidata, a Dassault Systèmes company, the global leader in creating end-to-end solutions supporting the entire clinical trial process, today announced that its myMedidata solution has been selected as the winner of the ‘Best Patient Portal’ award in the fifth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market.

Medidata’s myMedidata is one of the industry’s first patient portals to enable remote recruitment and virtual participation in clinical trials through a single web-based login, accessible on any device. myMedidata delivers a streamlined experience for patients and hospitals through one intuitive platform, expanding access to all of Medidata’s Patient Cloud solutions. 

By providing a better overall study experience, patients are more likely to actively participate in and remain on their clinical trial. myMedidata was built using input from the company’s Patient Insights group, where patient advocates regularly engage as a part of the Medidata software design and development life cycle.

“New drugs and treatments cannot be brought to market without the most important component – the patient and their ability to participate in clinical trials. Making research more patient-centric by giving patients the ability to virtually access and actively engage in their own treatments and health decisions will lead to faster and more effective drug development,” said Anthony Costello, President of Patient Cloud at Medidata. “We are honored that MedTech Breakthrough has recognized myMedidata for this award and we look forward to working with more and more of our customers who are actively rolling out decentralized trials programs with our technology.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,850 nominations from over 17 different countries throughout the world. 

“By creating a unified patient portal, patients can access all of their trial needs in one location, providing patients with the opportunity to view their own clinical data and increases their engagement with the study team, tracking progress and allowing for continued support throughout the study,” said James Johnson, Managing Director, MedTech Breakthrough. “This is a true breakthrough for an aspect of medicine and healthcare that is so incredibly important today and in the future. Congratulations to Medidata for winning our ‘Best Patient Portal’ award this year.”

myMedidata provides the industry’s single most comprehensive, integrated tool set for all aspects of patient-centered research, including electronic consent (eConsent) and clinical outcomes assessment (eCOA), wearable sensors, myMedidata LIVE (a web-based, live video conferencing capability), and patient recruitment/engagement through myMedidata Registries (coming early summer 2021). myMedidata also includes a research-based COVID-19 Symptom Tracker, designed to support research studies and advance scientific understanding of the virus.

Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

About Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 32,000 trials and 9 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,100+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes company (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE® Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all – consumers, patients and citizens. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit https://www.3ds.com